REED'S, INC. (REED)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

16 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013201220112010
Revenue$34.1M$38.0M$44.7M$53.0M$49.6M$41.6M$33.8M$38.1M$37.7M$42.5M$45.9M$43.4M$37.3M$30.0M$25.0M$20.4M
Gross profit$7.0M$11.4M$9.7M$12.1M$13.6M$12.8M$7.9M$10.7M$6.9M$9.2M$11.6M$13.0M$10.8M$9.1M$7.4M$6.1M
Operating expenses$22.1M$19.5M$19.1M$26.9M$29.6M$21.4M$22.7M$18.8M$18.6M$12.0M$14.3M$12.7M$11.7M$9.0M$7.7M$6.8M
Operating income−$15.1M−$8.1M−$9.4M−$14.8M−$16.0M−$8.6M−$14.9M−$8.1M−$11.7M−$2.8M−$2.7M$276,000−$869,000$136,000−$250,000−$724,000
EBITDAderived−$14.7M−$15.8M−$8.5M−$14.8M−$8.0M−$11.2M−$2.4M−$1.8M$1.0M−$319,000$874,000$403,000−$108,000
Net income−$15.8M−$13.2M−$15.5M−$20.1M−$16.4M−$10.2M−$16.1M−$10.3M−$18.4M−$5.0M−$4.0M−$754,000−$1.5M−$524,000−$941,000−$1.3M
Basic EPSper diluted share-$1.91-$9.81-$4.39-$9.07-$8.99-$0.17-$0.46-$0.41-$1.24-$0.37-$0.30-$0.06-$0.12-$0.05-$0.09-$0.14
Diluted EPSper diluted share-$1.91-$9.81-$4.39-$9.07-$0.18-$0.17-$0.46-$0.41-$1.24-$0.37-$0.30-$0.06-$0.12-$0.09-$0.14

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys5$9.31M disclosed value
Sells (SEC code S)2$11.8K disclosed value
7 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 4, 2025Form 4Era Regenerative Medicine Ltd +1TenPercentOwnerBuyCommon Stock · indirect1.08M28.21M
Nov 15, 2024Form 4Zaltzman Leon Michael +3TenPercentOwnerSellcommon stock · indirect4.5K$1.11$5.0K1.22M
Nov 14, 2024Form 4Zaltzman Leon Michael +3TenPercentOwnerSellcommon stock · indirect6.0K$1.13$6.8K1.22M
Sep 10, 2024Form 4Zaltzman Leon Michael +3TenPercentOwnerBuycommon stock · indirect531.2K$1.50$796.8K1.23M
Sep 10, 2024Form 4D&D Source of Life Holding Ltd. +1TenPercentOwnerBuyCommon Stock · indirect3.27M$1.50$4.90M4.43M